Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.06 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |